H.C. Wainwright Starts Roivant Sciences (ROIV) at Buy

H.C. Wainwright initiates coverage on Roivant Sciences (NASDAQ: ROIV) with a Buy rating and a price target of $14.00.

For an analyst ratings summary and ratings history on Roivant Sciences click here. For more ratings news on Roivant Sciences click here.

Shares of Roivant Sciences closed at $7.74 yesterday.

You May Also Be Interested In

• "Continue to See Vtama’s Profile as Truly Differentiated" - Truist Securities Bullish on Roivant Sciences (ROIV) with $15 Price Target
• Compass Point Starts Porch Group Inc. (PRCH) at Buy
• UPDATE: Piper Sandler Starts Amyris, Inc. (AMRS) at Neutral